Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY) is a Drug Manufacturers - General company in the Healthcare sector listed on the NYSE.

As of Oct 23, 2026: market cap $1.1T; returns 1 day -2.5%, 1 week +1.3%, 1 year +55.1%.

Eli Lilly and Company is a global pharmaceutical leader focused on the discovery, development, manufacturing, and marketing of prescription medicines across key therapeutic areas. The company's revenue generation is overwhelmingly driven by its product segment, which accounted for over 90% of its revenue in fiscal year 2024.

Groups LLY belongs to

• Dividend Payers
• Healthcare
• 25-Year Dividend Payers
• S&P 500
• Pharmaceuticals
• GLP-1 Agonists
• Metabolic Disorders
• Weight Management
• Biotechnology
• Alzheimer's Disease
• Breast Cancer Treatment
• Rheumatoid Arthritis
• Alopecia Areata
• Neuroscience
• Oncology
• Autoimmune Diseases
• Drug Discovery

LLY financial model: income statement, cash flow and balance sheet